Treatment with DISC-0974, Disc Medicine’s experimental antibody therapy for myelofibrosis-associated anemia, led to durable anemia responses across patient subgroups and clinically significant fatigue improvements in certain groups of people with myelofibrosis, according to…

Cero Therapeutics is expanding enrollment in an early clinical trial that’s testing its T-cell-based therapy candidate CER-1236, to now include people with hard-to-treat myelofibrosis. The Phase 1/1b CERTAIN-T study (NCT06834282) is a…

Until my myelofibrosis diagnosis, I didn’t really understand invisible illness. I understood pain that comes and goes, the kind most people experience. You pull a muscle, bang your head walking into a door, or…